Chairman Sanders’ Opening Statement The Senate Committee on Health, Education, Labor and Pensions convened on Tuesday, September 24th, to hear testimony from Lars Fruergaard Jørgensen, the CEO of Novo Nordisk, regarding the exorbitant prices of its diabetes medications, Ozempic and […]